Annual EBIT
-$436.05 M
+$131.88 M+23.22%
31 December 2023
Summary:
Biohaven Pharmaceutical Holding annual earnings before interest & taxes is currently -$436.05 million, with the most recent change of +$131.88 million (+23.22%) on 31 December 2023. During the last 3 years, it has fallen by -$321.55 million (-280.81%). BHVN annual EBIT is now -4231.92% below its all-time high of -$10.07 million, reached on 31 December 2015.BHVN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$178.17 M
+$155.60 M+46.62%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding quarterly earnings before interest & taxes is currently -$178.17 million, with the most recent change of +$155.60 million (+46.62%) on 30 September 2024. Over the past year, it has dropped by -$67.62 million (-61.17%). BHVN quarterly EBIT is now -5866.78% below its all-time high of -$2.99 million, reached on 01 March 2016.BHVN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$848.89 M
-$67.62 M-8.66%
30 September 2024
Summary:
Biohaven Pharmaceutical Holding TTM earnings before interest & taxes is currently -$848.89 million, with the most recent change of -$67.62 million (-8.66%) on 30 September 2024. Over the past year, it has dropped by -$353.14 million (-71.23%). BHVN TTM EBIT is now -28329.04% below its all-time high of -$2.99 million, reached on 01 March 2016.BHVN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BHVN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.2% | -61.2% | -71.2% |
| 3 y3 years | -280.8% | -250.2% | -698.0% |
| 5 y5 years | -90.6% | -29.4% | -73.6% |
BHVN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -280.8% | +23.2% | -250.2% | +46.6% | -698.0% | at low |
| 5 y | 5 years | -280.8% | +23.2% | -250.2% | +46.6% | -698.0% | at low |
| alltime | all time | -4231.9% | +23.2% | -5866.8% | +46.6% | <-9999.0% | at low |
Biohaven Pharmaceutical Holding EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$178.17 M(-46.6%) | -$848.89 M(+8.7%) |
| June 2024 | - | -$333.77 M(+82.2%) | -$781.27 M(+44.3%) |
| Mar 2024 | - | -$183.24 M(+19.2%) | -$541.51 M(+24.2%) |
| Dec 2023 | -$436.05 M(-23.2%) | -$153.71 M(+39.0%) | -$436.05 M(-12.0%) |
| Sept 2023 | - | -$110.55 M(+17.6%) | -$495.75 M(+9.5%) |
| June 2023 | - | -$94.01 M(+20.9%) | -$452.84 M(-18.5%) |
| Mar 2023 | - | -$77.78 M(-63.6%) | -$555.94 M(-2.1%) |
| Dec 2022 | -$567.93 M(+159.4%) | -$213.41 M(+215.5%) | -$567.93 M(+40.1%) |
| Sept 2022 | - | -$67.64 M(-65.7%) | -$405.40 M(+3.1%) |
| June 2022 | - | -$197.11 M(+119.6%) | -$393.26 M(+100.5%) |
| Mar 2022 | - | -$89.77 M(+76.4%) | -$196.15 M(+84.4%) |
| Dec 2021 | -$218.90 M(+91.2%) | - | - |
| Dec 2021 | - | -$50.88 M(-8.3%) | -$106.38 M(-55.7%) |
| Sept 2021 | - | -$55.49 M(-69.9%) | -$239.87 M(-64.4%) |
| Dec 2020 | -$114.51 M(-76.6%) | - | - |
| Dec 2020 | - | -$184.38 M(+9.3%) | -$672.89 M(+7.5%) |
| Sept 2020 | - | -$168.77 M(+4.5%) | -$626.17 M(+13.5%) |
| June 2020 | - | -$161.54 M(+2.1%) | -$551.56 M(-6.8%) |
| Mar 2020 | - | -$158.20 M(+14.9%) | -$591.92 M(+21.0%) |
| Dec 2019 | -$489.10 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | - | -$137.66 M(+46.2%) | -$489.10 M(+22.2%) |
| Sept 2019 | - | -$94.15 M(-53.4%) | -$400.40 M(+10.6%) |
| June 2019 | - | -$201.90 M(+264.6%) | -$361.89 M(+82.1%) |
| Mar 2019 | - | -$55.38 M(+13.1%) | -$198.73 M(-13.1%) |
| Dec 2018 | -$228.73 M(+81.3%) | - | - |
| Dec 2018 | - | -$48.96 M(-12.0%) | -$228.73 M(+10.3%) |
| Sept 2018 | - | -$55.65 M(+43.6%) | -$207.39 M(+6.7%) |
| June 2018 | - | -$38.74 M(-54.6%) | -$194.37 M(+0.6%) |
| Mar 2018 | - | -$85.38 M(+209.0%) | -$193.30 M(+53.2%) |
| Dec 2017 | -$126.18 M(+100.1%) | - | - |
| Dec 2017 | - | -$27.63 M(-35.2%) | -$126.18 M(+2.1%) |
| Sept 2017 | - | -$42.62 M(+13.1%) | -$123.64 M(+13.2%) |
| June 2017 | - | -$37.68 M(+106.4%) | -$109.19 M(+39.4%) |
| Mar 2017 | - | -$18.25 M(-27.2%) | -$78.33 M(+24.2%) |
| Dec 2016 | -$63.06 M(+526.5%) | - | - |
| Dec 2016 | - | -$25.09 M(-10.9%) | -$63.06 M(+66.1%) |
| Sept 2016 | - | -$28.17 M(+313.1%) | -$37.97 M(+287.3%) |
| June 2016 | - | -$6.82 M(+128.4%) | -$9.80 M(+228.4%) |
| Mar 2016 | - | -$2.99 M | -$2.99 M |
| Dec 2015 | -$10.07 M | - | - |
FAQ
- What is Biohaven Pharmaceutical Holding annual earnings before interest & taxes?
- What is the all time high annual EBIT for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding annual EBIT year-on-year change?
- What is Biohaven Pharmaceutical Holding quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding quarterly EBIT year-on-year change?
- What is Biohaven Pharmaceutical Holding TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Biohaven Pharmaceutical Holding?
- What is Biohaven Pharmaceutical Holding TTM EBIT year-on-year change?
What is Biohaven Pharmaceutical Holding annual earnings before interest & taxes?
The current annual EBIT of BHVN is -$436.05 M
What is the all time high annual EBIT for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high annual earnings before interest & taxes is -$10.07 M
What is Biohaven Pharmaceutical Holding annual EBIT year-on-year change?
Over the past year, BHVN annual earnings before interest & taxes has changed by +$131.88 M (+23.22%)
What is Biohaven Pharmaceutical Holding quarterly earnings before interest & taxes?
The current quarterly EBIT of BHVN is -$178.17 M
What is the all time high quarterly EBIT for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high quarterly earnings before interest & taxes is -$2.99 M
What is Biohaven Pharmaceutical Holding quarterly EBIT year-on-year change?
Over the past year, BHVN quarterly earnings before interest & taxes has changed by -$67.62 M (-61.17%)
What is Biohaven Pharmaceutical Holding TTM earnings before interest & taxes?
The current TTM EBIT of BHVN is -$848.89 M
What is the all time high TTM EBIT for Biohaven Pharmaceutical Holding?
Biohaven Pharmaceutical Holding all-time high TTM earnings before interest & taxes is -$2.99 M
What is Biohaven Pharmaceutical Holding TTM EBIT year-on-year change?
Over the past year, BHVN TTM earnings before interest & taxes has changed by -$353.14 M (-71.23%)